Evidence map›Paper›PMID 39552980›Full record

ArticleCureus2024

A Case of Progressive Multifocal Leukoencephalopathy Caused by Epcoritamab.

Chifumi Iseki, Kazuo Nakamichi, Kenichi Ishizawa, Yasuyuki Ohta, Tomomi Toubai

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chifumi IsekiDivision of Neurology and Clinical Neuroscience, Department of Internal Medicine Ⅲ, Yamagata University, Yamagata, JPN.
Kazuo NakamichiDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, JPN.
Kenichi IshizawaDepartment of Nursing, Faculty of Health Sciences, Tohoku Fukushi University, Sendai, JPN.
Yasuyuki OhtaDivision of Neurology and Clinical Neuroscience, Department of Internal Medicine Ⅲ, Yamagata University, Yamagata, JPN.
Tomomi ToubaiDivision of Hematology and Cell Therapy, Department of Internal Medicine Ⅲ, Yamagata University, Yamagata, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A female patient aged in her 50s had presented with the onset of follicular lymphoma (FL) with left mandibular swelling, with a pathological grade of 1 and clinical stage of Ⅳ (Ann Arbor staging). Cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab (R-CHOP) resulted in complete molecular remission (CMR). The patient experienced two recurrences, and treatments were successful; however, the side effect of continuous lymphocytopenia existed eight years after the onset. For the third recurrence of FL, weekly epcoritamab therapy was administered with a white blood cell count of 2,010 /μL with neutrophils of 1,240/μL, lymphocytes of 430/μL, red blood cells of 390 × 10

Indexed as

anti-cd-20follicular lymphomalymphocytopeniaprogressive multifocal leukoencephalopathy (pml)subcortical

Identifiers

PMID39552980
PMCPMC11567728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.